A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
Public ClinicalTrials.gov record NCT01877655. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Protective Efficacy and Safety of a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study was to evaluate the efficacy of ASP0113 compared with placebo as measured by a primary composite endpoint of overall mortality and CMV end organ disease (EOD) through 1 year post-transplant. Safety of ASP0113 in participants undergoing allogeneic HCT will also be evaluated.
Study identification
- NCT ID
- NCT01877655
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 514 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 11, 2013 (Actual)
- Primary completion
- Sep 28, 2017 (Actual)
- Completion
- Mar 1, 2022 (Actual)
- Last update posted
- Oct 24, 2024
2013 – 2022
United States locations
- U.S. sites
- 27
- U.S. states
- 22
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10028 | Birmingham | Alabama | 35294 | — |
| Site US10044 | Tucson | Arizona | 85724 | — |
| Site US10035 | San Francisco | California | 94143 | — |
| Site US10026 | Stanford | California | 94305 | — |
| Site US10030 | Tampa | Florida | 33612 | — |
| Site US10012 | Atlanta | Georgia | 30322 | — |
| Site US10013 | Chicago | Illinois | 60612 | — |
| Site US10007 | Indianapolis | Indiana | 46237 | — |
| Site US10020 | Westwood | Kansas | 66205 | — |
| Site US10010 | Louisville | Kentucky | 40202 | — |
| Site US10043 | Baltimore | Maryland | 21201 | — |
| Site US10011 | Baltimore | Maryland | 21205 | — |
| Site US10021 | Boston | Massachusetts | 02114 | — |
| Site US10036 | Rochester | Minnesota | 55905 | — |
| Site US10042 | St Louis | Missouri | 63110 | — |
| Site US10023 | Hackensack | New Jersey | 07601-2105 | — |
| Site US10047 | New York | New York | 10032 | — |
| Site US10027 | Rochester | New York | 14642 | — |
| Site US10025 | Chapel Hill | North Carolina | 27514 | — |
| Site US10016 | Nashville | Tennessee | 37232 | — |
| Site US10002 | Dallas | Texas | 75246 | — |
| Site US10045 | Houston | Texas | 77030 | — |
| Site US10046 | Salt Lake City | Utah | 84143 | — |
| Site US10031 | Richmond | Virginia | 23298 | — |
| Site US10039 | Seattle | Washington | 98108 | — |
| Site US10024 | Seattle | Washington | 98109 | — |
| Site US10019 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01877655, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01877655 live on ClinicalTrials.gov.